Ophthalmology
Eyes & vision clinical trials
Eye disease and conditions that affect sight. We’re tracking 1,816 recruiting studies in this area right now.
By phase
- Not applicable1,253
- Phase 3130
- Phase 2121
- Phase 1120
- Phase 491
- Phase 1/Phase 285
- Phase 2/Phase 316
Top conditions
- Glaucoma108
- Cataract90
- Myopia89
- Diabetic Retinopathy52
- Dry Eye42
- Keratoconus34
- Age-Related Macular Degeneration33
- Retinitis Pigmentosa31
- Sjogren's Syndrome29
- Diabetic Macular Edema26
- Eye Diseases26
- Graves Disease26
- Amblyopia24
- Astigmatism23
- Dry Eye Disease (DED)23
- Multiple Sclerosis23
- Retinal Disease23
- Macular Degeneration22
Leading sponsors
- Zhongshan Ophthalmic Center, Sun Yat-sen University28
- Second Affiliated Hospital, School of Medicine, Zhejiang University23
- Medical University of Vienna19
- Fondation Ophtalmologique Adolphe de Rothschild18
- National Taiwan University Hospital17
- Assistance Publique - Hôpitaux de Paris16
- Eye & ENT Hospital of Fudan University15
- National Eye Institute (NEI)15
- Shanghai Eye Disease Prevention and Treatment Center15
- Duke University13
Where studies are running
- California141
- Arizona66
- Texas41
- Maryland39
- New York34
- Massachusetts33
- Florida32
- Alabama27
- North Carolina21
- Pennsylvania21
Recruiting studies1,816 total
- NCT06151587RecruitingPhase 3
Eye drop to slow myopia in children
This study tests an eye drop (QLM3004) to see if it can slow down the progression of nearsightedness (myopia) in children. It might be a good option if your child is between 6 and 12, has mild to moderate nearsightedness, and hasn't used other myopia treatments before.
Wenzhou, ZhejiangAges 6–12 - NCT06161415RecruitingPhase 1
Laquinimod eye drops before vitrectomy: safety study
This trial tests a new eye drop called Laquinimod for people who are already scheduled for a vitrectomy. The drops are given before surgery to see if they are safe and how they spread in the eye.
Palo Alto, CaliforniaAges 18 years+ - NCT06162013RecruitingPhase 2
NAD supplement trial for atypical parkinsonism
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
Oslo, OsloAges 30–85 - NCT06162234Recruiting
High Myopia Study in Wuhan
This study looks at how high myopia (severe nearsightedness) affects the eye over time. It aims to better understand the condition and improve care for people with high myopia.
Wuhan, HubeiAges 18–65 - NCT06163989Recruiting
Eye drops for gamers with dry eyes
This trial tests whether lubricating eye drops can help keep gamers' eyes comfortable and healthy. If you play games for 2+ hours a day and have dry eyes, you might be able to join.
Birmingham, West MidlandsAges 18 years+ - NCT06174948Recruiting
CUE1 device for Parkinson's and related movement disorders
This trial tests a small device called CUE1 that gives gentle vibrations on the chest to help improve movement and balance in people with Parkinson's disease and similar conditions. It may help if you have trouble with walking or stability.
LondonAges 18 years+ - NCT06177639Recruiting
A new eye camera designed for children and babies
This trial is testing a new, more comfortable eye camera designed for children and babies. It takes wide-angle pictures of the back of the eye (retina) to see if it works better than current cameras. You or your child can join even if you have healthy eyes or an eye condition.
Durham, North CarolinaAges 4 weeks+ - NCT06177977Recruiting
New imaging test for early-onset retinal disease
This study tests a new type of eye imaging to better detect and diagnose early-onset retinal dystrophies in children up to 8 years old. It may help find these conditions sooner and guide treatment.
Durham, North CarolinaAges birth–8 years - NCT06182605Recruiting
New tools for cataract surgery
This trial is testing special tools to help doctors perform cataract surgery more safely and easily. It is for people who need cataract surgery and do not have eye inflammation, high eye pressure, or other serious health issues.
Hangzhou, ZhejiangAges 18–80 - NCT06190626Recruiting
A study of eye disease in Zellweger spectrum disorder over time
This study follows people with Zellweger spectrum disorder (ZSD) to understand how their eye condition develops over time. It aims to help doctors treat the disease better in the future.
Rochester, New YorkAges Any age - NCT06201455Recruiting
Glaucoma surgery study for people with controlled eye pressure and cataracts
This study tests a new surgery that combines cataract removal with a glaucoma procedure to lower eye pressure in people with primary open-angle glaucoma. It's for people whose eye pressure is controlled with 1 to 4 medications but who also have significant cataracts.
Guangzhou, GuangdongAges 40–85 - NCT06203106Recruiting
NYSCF Scientific Discovery Biobank
This study collects blood, saliva, or skin samples from people with certain neurological conditions and from healthy volunteers to help researchers better understand and find treatments for these diseases.
New York, New YorkAges 4 weeks+ - NCT06211218Recruiting
AI screening for multiple corneal diseases
This study uses artificial intelligence to look at slit-lamp images of your eye to screen for different corneal diseases. It may help find problems early when they are easier to treat.
Tianjin, Tianjin MunicipalityAges Any age - NCT06211907Recruiting
Small Macular Holes Treated With Air Only
This study tests whether using just a gas bubble (air) can help close small macular holes, avoiding more complex surgery. It's for people with a small, recent macular hole who haven't had eye surgery before.
Thessaly, ThessalyAges 18 years+ - NCT06213649RecruitingPhase 3
Ulcer treatment trial for active eye infection
This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.
San Francisco, CaliforniaAges 8 years+ - NCT06219252Recruiting
Comparing lens power methods during cataract surgery
This study compares two ways to choose the right lens power during cataract surgery: one uses a special measurement during surgery, the other uses standard pre-surgery measurements. The goal is to see which method gives you better vision after surgery.
Mexico City, CuauhtemocAges 40 years+ - NCT06220474Recruiting
Radiofrequency treatment for stubborn dry eye
This trial tests a non-invasive radiofrequency treatment for people with meibomian gland dysfunction (a type of dry eye) that hasn't improved with standard treatments. It aims to see if this therapy can safely help your eyes feel better.
Hong KongAges 18 years+ - NCT06223048RecruitingPhase 2
Study of AMDX-2011P for primary open angle glaucoma
This trial tests an investigational drug called AMDX-2011P for people with primary open angle glaucoma in both eyes. It aims to see if the drug can help protect the optic nerve and preserve vision.
Phoenix, ArizonaAges 22 years+ - NCT06227611Recruiting
Testing vision grids for glaucoma patients
This trial compares different visual field test patterns to detect central vision loss in glaucoma patients who already show thinning of retinal cells. The goal is to find which test pattern works best for early detection.
RomeAges 18 years+ - NCT06237829Recruiting
Testing touch aids for people who are blind
This study tests how well touch-based aids help people who are blind or visually impaired understand math plots. The goal is to see if these tools work better for everyday use.
Newark, DelawareAges 16 years+ - NCT06241209Recruiting
Vision rehab for hemianopsia after stroke or brain injury
This study tests a vision rehabilitation program for people who lost part of their vision on the same side in both eyes after a stroke or brain injury. The program uses flashing lights to help retrain your brain, so it is important that you do not have seizures triggered by lights.
Edmonton, AlbertaAges 18 years+ - NCT06242379RecruitingPhase 1/Phase 2
Testing stem cell particles for retinitis pigmentosa
This trial tests whether tiny particles from stem cells, called extracellular vesicles, can help people with retinitis pigmentosa. It aims to see if these particles are safe and can improve vision.
Bangkok Noi, BangkokAges 18 years+ - NCT06243497Recruiting
Comparing eye fluid and tear markers before and after UCP
This study compares levels of inflammatory markers (cytokines) in the fluid inside your eye and your tears before and after a procedure called UCP (ultrasound cycloplasty) to treat glaucoma. It aims to understand how the eye responds, which may lead to better treatments for high eye pressure.
Guangzhou, GuangdongAges Any age - NCT06246136Recruiting
Laser treatment for glaucoma during cataract surgery
This study tests a new laser treatment (ELIOS) for people with open-angle glaucoma who also need cataract surgery. It aims to see if the laser is safe and effective at lowering eye pressure while removing the cataract.
LeuvenAges 40 years+
Common questions
- How many eyes & vision clinical trials are recruiting?
- Clin2 is tracking 1,816 recruiting ophthalmology studies from the U.S. registry right now, out of 2,919 we cover in this area in total.
- What does “Eyes & vision” cover here?
- Eye disease and conditions that affect sight. We group each study into eyes & vision based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a eyes & vision trial near me?
- Use the search to filter eyes & vision studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.